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Chapter 1
Introduction
Cancer represents the major public health problem for modern society. Despite signif-
icant advances in conventional treatment and basic studies providing a better compre-
hension of cancer biology, only few improvements in therapy efficacy have been reached
in the last years. This poor clinical outcome, apart from some notable exceptions, il-
lustrates an unmet clinical need for new therapeutic approaches capable of delivering
an effective long-lasting protection against disease recurrence.
1.1 Photodynamic Therapy and Bystander Effects
Photodynamic therapy (PDT) is an approved therapeutic modality, currently used in
the treatment of neoplastic and non malignant diseases, which can exert a selective
cytotoxic activity toward malignant cells and has the potential to meet many unreached
medical needs[3].
The procedure of PDT involves three fundamental components: the photosensitizer
(PS), a drug systemically or topically delivered, which remains inactive and produces
negligible side effects until photoactivation, the excitation light and molecular oxygen.
Together they initiate a photochemical reaction that produces singlet oxygen 1O2, a
highly reactive molecule which can cause important and rapid toxicity in target cells
leading to apoptosis or necrosis. More specifically, after light absorption, one of the
two electrons with opposite spin in the low energy singlet state of the ground state
PS is excited into a high-energy orbital. This short-lived species can then decay to
the ground state by emitting light or by internal conversion (most PS molecules are
fluorescent). Alternatively, the excited singlet state may undergo intersystem crossing
to form a relatively long-lived, a few µs, excited triplet-state. The excited triplet state
PS can induce chemical changes in a neighbouring molecule via two main pathways,
called type-I and type-II photochemical reaction. Firstly, in a type-I reaction, activated
triplet state PS can react directly with other adjacent molecules and transfer a proton
or an electron to form a radical anion or radical cation, respectively, which may further
react with molecular oxygen or nitric oxide (NO) to produce reactive oxygen species
(ROS) and reactive nitrogen species (RNS), respectively. Alternatively, in a Type II
reaction, the triplet PS can react directly with molecular oxygen(O2) to form excited
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state singlet oxygen[80]. Both Type I and Type II reactions can occur simultaneously,
and the ratio between these processes depends on the type of PS used, the concentra-
tions of substrate and O2[20]. As a result of these photoreactions, cellular organelles
and membranes are subjected to photodamage, whose extent and cytotoxicity depends
on several independent factors: the type of PS, its extracellular and intracellular lo-
calization, the total dose administered, the total light exposure dose and intensity, the
oxygenation state of the tissue and the time between the administration of the drug
and light exposure.
Photodynamic therapy effects are not restricted to direct cytotoxicity but also
involve damage to the tumor vasculature and induction of a robust inflammatory re-
sponse. Selectivity of this therapeutic approach is derived from the ability of the PS
drug to accumulate in tumor environment and light delivery to the tumor locus. The
treatment does not produce changes in tissue temperature leading to minimal fibro-
sis and preserving mechanical integrity of hollow organs undergoing PDT. Minimal
side effects on normal tissue and lack of resistance mechanism make this approach a
valuable therapetic option[3].
Cell death and the bystander effect are crucial for both the efficacy of cancer therapy
and the modulation of anti-tumor immune response. The effect refers to a process
whereby untreated cells exhibit either the deleterious or beneficial indirect effects as a
result of signals received from nearby targeted cells[9].Various molecular players and
pathways have been suggested to mediate the bystander effects, nevertheless to date
it is not known which are the key molecules and cellular mechanisms underpinning
cell death signal propagation. Several reports suggest the involvement of both NO
and RNS in mediating the bystander effect. Nevertheless their role in the process
has not been totally defined since these molecules can either inhibit or sustain tumor
progression. From a molecular point of view, radiation-induced bystander response
is based on two main mechanisms of action, which involve both directly contacting
cells via gap junctions and not physically connected cells through the release of soluble
factors. These factors, preferentially transferred through extracellular medium from
irradiated to non irradiated cells, include lipid peroxide products, inosine nucleotides
and cytokines such as tumor necrosis factor-α (TNFα). Reactive oxygen species (ROS),
such as superoxide radicals, are also involved in bystander cell signals[82]. Furthermore,
a growing number of findings support the importance of NO in intercellular signal
transduction pathways initiated by ionizing radiation.
1.2 Nitric Oxide as a signalling molecule
NO is a short lived, ubiquitous free radical gas with a key role in many physiological
and pathological processes. Its role as a signalling molecule was first determined as
the endothelium derived relaxing factor in 1987[41].
NO is synthesized by Nitrix Oxide Synthase enzymes (NOS) from arginine and O2
in both Ca2+-dependent or independent ways, depending on wich enzyme is involved.
Three different NOS enzyme are present in mammals: nNOS (also known as Type
I, NOS-I and NOS-1 being the first isoform found) predominating in neuronal tissue;
iNOS (also known as Type II, NOS-II and NOS-2), which is inducible in a wide range
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of cells and tissues, primarily in macrophages; and eNOS (also known as Type III,
NOS-III and NOS-3) predominantly found in endothelial cells[50]. These different en-
zymes are products of different genes, with different localization, regulation, catalytic
properties and inhibitor sensitivity, and with 51-57% homology between the human
isoforms, suggesting the existence of a common ancestral NOS gene.
The importance of NO as signalling molecule and its biological effects have now
been characterized in a number of tissues. Smooth muscle relaxation is an important
function for NO, playing a key role in blood vessels vasodilation. NO synthesis from
nNOS and its importance in neurotransmission is also well established both peripher-
ally[104] and centrally in the process of long term potentiation or depression[93]. In
particular, NO produced by eNOS and nNOS is released for short periods of time and
acts as a transduction mechanism whereas NO released from iNOS after activation
of macrophages by cytokines is synthesized for long periods and acts as a cytotoxic
molecule for invading microorganisms and tumor cells[87]. NO plays also a role in
cellular respiration regulation, as nanomolar concentrations of NO reversibly inhibit
cytochrome oxidation and mitochondrial respiration. Higher concentrations of NO can
irreversibly inhibit the respiratory chain leading to PTP opening and cell death[17].
Before the discovery of NO physiological production by NOS, NO was considered
a pollutant. It’s now clear that the physical properties of NO make it particularly well
suited to its role as a signalling agent, diffusion coefficient for NO in aqueous solution is
reported to be 3300 µm2/s [65]. The relatively long lifetime of NO, despite its radicalic
nature, allows it to reach neighbouring target cells. NO is then oxidized to NO3 and
NO2 under physiological conditions, thus no separate mechanism for its destruction is
required.
The main receptor for NO in target cells is the soluble isoform of guanylate cyclase
(sGC), one of the two enzymes that produce cGMP and the only definitive receptor for
NO. For this reasons, sGC is intimately involved in many signal transduction pathways
in the cardiovascular and nervous system[43]. sGC is a heterodimeric protein composed
of α and β subunits. The β-subunits contains a ferrous heme group that is a highly
selective receptor for NO. Activation of the sGC by NO induces a 300-fold increase
in its activity[67] producing a burst of cGMP. The rise in cGMP concentration allow
sGC to transmit a NO signal to cGMP dependent protein kinase, cGMP-dependent
cation channels and cGMP-dependent phosphodiesterase. cGMP-dependent kinases in
turn produce a lowering of intracellular Ca2+, leading to effects such as smooth muscle
relaxation.
1.3 Nitric Oxide Synthases: structure and function
NOS activation is strictly dependent on enzyme structure and shows remarkable dif-
ferences between different isoforms. Importantly, the activities of all isoforms depend
on their binding to calmodulin(CaM).
To become active each NOS enzyme must assemble in a dymeric structure of two
subunits[27]. Each subunit in a NOS dymer exhibit an N-terminal oxygenase domain
that binds a heme group, a tetrahidrobiopterin cofactor and the substrate arginine.
Additionally, the C-terminal reductase domain binds flavin mononucleotide (FMN),
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flavin adenine dinucleotide (FAD), and nicotinamide adenine dinucleotide phosphate
(NADPH). Between these domains a CaM binding site of 20-25 amminoacids is found.
CaM bound to NOS plays a key role in NO synthesis by allowing electron transfer to
the heme group. When the CaM-NOS dymer is assembled, electron transfer starts from
NADPH, proceeds through FAD and FMN in one dymer. Electrons are then transfered
to the heme group on the second subunit, as shown in figure 1.1. CaM intervene in
the process facilitating both intra-domain and inter-domain electron transfer[67].
Figure 1.1: NOS dymeric structure scheme[45]
CaM is a small Ca2+ binding protein formed by two lobes that contains two E-
F hands each one[52] capable of bind two Ca2+ in a cooperative way, providing on
the whole four Ca2+ binding sites. After Ca2+ binding, CaM can activate more than
30 different enzyme. Fully activation of target proteins by CaM typically requires
occupancy of all four Ca2+-binding sites. CaM binds to each NOS subunit in a 1:1
stoichiometry but with different affinities depending on NOS type. iNOS display a
considerable higher affinity for CaM then eNOS and nNOS. Moreover iNOS binds
CaM even in absence of Ca2+, whereas eNOS and nNOS bind CaM only in presence
of Ca2+. Dissociation of Ca2+ from bound CaM takes place in two steps. First, rapid
Ca2+ dissociation from CaM N-terminal lobe leads to NO synthesis blockage. Then
a slower Ca2+ dissociation from the C-terminus occurs and CaM dissociates from
NOS[79][18].
As mentioned above CaM regulates NOS activity by controlling electron transfer
to the heme group. This effect is due to a conformational rearrangement that sets the
FMN subdomain in closer proximity to the oxygenase heme domain and involve two
regulatory elements of the enzyme[103].
Autoinhibitory loop is a regulatory element unique of eNOS and iNOS. It consists
of a 40-50 amino acid insert in the FMN binding module that is not present in iNOS.
Similar structures have been reported also in a number of CaM activated enzymes.
Deletion of this insert in eNOS and iNOS reduces EC50 for Ca
2+-saturated CaM and
also enables some residual NO synthesis in the absence of CaM, confirming the function
of this structure and its contribution to Ca2+ dependence of eNOS and nNOS. How this
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inhibitory element inhibits enzyme activity is not completely clear, however enzyme
activation is fully dependent on a movement of the autoinhibitory insert, which could
be affected by the Ca2+-saturated CaM.
Another unique regulatory element of eNOS and nNOS is the C-terminal extension,
formed by a tale of 20-40 amino acids. Deletion of different residues from eNOS and
iNOS extension accelerates electron transfer into flavins domain and also leads a lower
Ca2+ dependence and an increase in catalytic activities. Importantly, a phosphoryla-
tion site in the C-terminal extension can modulate Ca2+ dependence of the enzyme.
In the absence of CaM, the C-terminal extension covers the NADPH, FMN and FAD
subdomain of the enzyme preventing electron transfer to the redox partners[7].
Thus, the autoinhibitory loop and the C-terminal tail inhibit the activity of eNOS
and iNOS in the absence of Ca2+-saturated CaM. Other structural elements along with
protein phosphorylation also regulate Ca2+/CaM binding and tune enzyme activity[4].
When CaM is bound, NOS catalyze the redox convertion of L-arginine (L-Arg) in
L-citrulline (L-Cit) and NO through a complex reaction pathway that can be divided
in two major steps with Nω-hydroxy-L-arginine (NOHA) as intermediate product[94]:
L-Arg + O2 +NADPH −−→ NOHA+NADP
+ (1.1)
2NOHA +O2 + 2NADPH −−→ 2L-Cit + NADP
+ +NO (1.2)
The essential role of FAD and FMN cofactors in the reductase domain is to accept two
electrons from NADPH and pass them on to a one-electron acceptor heme domain by
forming stable semiquinone radical intermediates. The monooxygenase II step involves
the reduction of heme ferric to ferrous ion and O2 binding. This form of the enzyme
then reacts with Nω-hydroxy-L-arginine to form its radical and a heme-peroxy complex.
The Nω-hydroxy-L-arginine radical and the peroxy complex then react with each other
in a ’radical rebound’ mechanism to generate citrulline and NO, and to regenerate the
ferric haem iron.
1.4 Non-enzymatic Nitric Oxide production
In addition to the well known generation from NOS, new studies over the last years
have demonstrated additional mechanisms for NO production in biological tissues.
The first evidence of NOS/L-Arg independent NO synthesis was reported in ischaemic
heart by direct reduction or disproportionation of nitrite (NO−2 ) to NO under acidotic
and highly reduced conditions[55].
Further studies have confirmed the role of nitrite as an important storage form
of NO that can be released in a complete enzyme-independent pathway; moreover
correlative EPR measurements of NO and P-NMR measurements of intracellular pH
demonstrated that the magnitude of NO generation from nitrite increases as the pH of
the tissue decreases[55]. The magnitude of nitrite disproportionation process was also
quantitatively characterized by means of EPR and chemiluminescence studies and the
corresponding rate law of NO formation was obtained. The reaction scheme proposed
for this process by Zweier et al.[54] involves the equilibrium that takes place between
NO−2 and nitrous acid (HNO2) under acidic conditions. Nitrous acid in turn exists in
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equilibrium with nitrosonium acid(NOOH) which can react with NO−2 to give N2O3
an subsequently NO. The rate of NO production by this process was estimated to be:
d[NO]
dt
=
k1[NO
−
2 ][HNO2]
[NO−2 ] + kβ
(1.3)
where [HNO2] can be related to initial nitrite concentration and [H
+]. Under phys-
iological pH and nitrite concentration a small rate of NO production of 0.5pM/s is
predicted whereas when pH falls down at values as low as 5.5, NO production can
reach a rate of tens of nM/s[54].
Several other reactions have been shown to lead to NOS-independent NO produc-
tion that include the reduction of nitrite to NO catalyzed by microbial nitrite reductase
and xanthine oxidoreductase under hypoxic conditions. Moreover the mitochondrial
respiratory chain and also other heme containing enzymes can take part in nitrite re-
duction[97]. Finally, hydrogen peroxyde reacting with L-Arg or similar compound was
reported to be involved in NO production[74].
Of particular relevance for PDT, it was recently reported that aluminum phthalo-
cyanine (AlPc), a common PS used also in our experiments, can buffer NO and can be
used as a NO carrier in biological system. As shown by Silva et al.[91] NO complexa-
tion to AlPc depends on the oxidation state of the latter. Particularly, NO binds more
strongly to AlPc in the reduced state than in the oxidized state. These studies suggest
that AlPc can act as a store for NO that can be released during the PS oxidation that
takes place following photoactivation.
1.5 The dual role of nitric oxide in cancer biology
At physiological concentration NO acts as a signal molecule in many processes, such
as blood flow regulation, smooth muscle relaxation, iron homeostasis, platelet reac-
tivity and neurotransmission[56]. At higher concentrations, NO provides cytotoxic de-
fensive mechanisms against pathogens and tumors[72]. In general, high NO/RNS are
thought to exert a pro-apototic action[106]. Both NO and RNS induce post transla-
tional modification in target proteins, block cellular respiration interfering with the
electron transport chain in the mitochondria resulting in cytochrome C release and
apoptosis initiation[57]. High NO concentration can also cause DNA damage that can
both start oncogenesis or induce apoptosis in cancer cells. Despite these effects NO role
in cancer teraphy is strongly debated as, some cases, NO can promote tumor growth
and resistance. An example of this dual role is inhibition of cell death by S-nitrosation
of the active site cysteine residue in caspases[28]. Moreover, it has been reported that
tumors producing high level of NO or incubated with NO donors show a decrease in
cell death after photosensitization[35].
1.6 Calcium signalling in cancer
Ca2+ ion is a ubiquitous intracellular signalling molecule that is required to regulate
a large variety of cell processes like fertilization, cell proliferation and differentiation,
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transcription factor activation and apoptosis modulation[13]. Due to its ubiquity and
versatility, Ca2+ probably plays an important role as a signalling agent also in cancer
cells, where Ca2+ signalling networks could be remodelled because of altered expression
of key elements of the so-called Ca2+ signalling toolkit[77].
The latter comprises channels, pumps and receptors that together modulate Ca2+
dynamics generating complex spatio temporal organized signalling patterns. At rest,
the cytosolic free Ca2+ concentration ([Ca2+]c) is about 100 nM. This low basal level
can be rapidly increased by Ca2+ influx from the extracellular medium, where Ca2+
concentration typically about 1 mM. A rapid rise of [Ca2+]c can be also triggered by
release of Ca2+ from internal stores, like endoplasmic reticulum (ER), mitochondria,
Golgi apparatus and lysosomes and also from Ca2+ buffer proteins. Influx of Ca2+
from the extracellular mileau is mediated by different channels that can be divided
into three main family: the voltage operated channels (VOCs) which open in response
to membrane depolarization, the receptor operated channels(ROCs) which open in
response to the extracellular binding of a ligand and the store operated channels (SOCs)
that is activated by depletion of intracellular stores. Ca2+ release from the ER is
mediated by receptor operated channels, particularly ryanodyne and inositol 1,4,5-
trisphosphate (IP3) receptors on the endoplasmic reticulum[85].
Figure 1.2: Ca2+ dynamics pathways
After surging in response to a stimulus, [Ca2+]c is rapidly reduced to the rest-
ing level by exchangers, like the Na-Ca exchangers, and pumps, like Ca2+-ATPases
(PMCA) in the plasma membrane and sarco-endoplasmic reticulum ATPases(SERCA)
in the ER. Also mitochondria, through the mitocondrial calcium uiporter (MCU), and
the Golgi apparatus and lysosomes through secretory pathway Ca2+ATPases, can con-
tribute to reduce [Ca2+]c after a stimulus[48].
Peculiarities of Ca2+ dynamics in cancer cells emerge from deregulation of one or
more of these toolkit components. The most dysregulated channels identified in hu-
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man tumors are TRPM8, ORAI1 and TRPV6 which are upregulated in prostate, breast
and colon cancers; SERCA2 is downregulated in lung, colon and thyroid tumors and
PMCA, whose isoforms are deregulated in breast, lung colon and oral neoplasia[42].
Moreover, ORAI1 and TRPM7 are reported to be overexpressed in human breast can-
cer where they promote tumor cell migration, invasion and metastasis[24] and ATP2C1
and ATP2C2 are upregulated in breast cancer. This alterations could affect Ca2+ sig-
nalling in cancer cells modulating the resting Ca2+ concentration in the cytoplasm, ER
and other stores. Either the overexpression of protein like IP3R channels that cause
Ca2+ leakage from ER, or the lower expression of SERCA, reducing Ca2+ sequestra-
tion can cause a lower level of endoplasmic reticulum Ca2+ content. This fact could
lead to a decrease in apoptotic cell death of cancer cells because Ca2+ release from ER
and subsequent uptake from mitochondria play a key role in trigger apoptosis.
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Summary
The aim of this study is to cast new light on the role of NO and Ca2+ in bystander
effect propagation during PDT. Prior works suggests the involvement of NO and RNS
in bystander effect but only indirect evidences of their role were reported. The first
goal of our work was to verify the onset of NO signals in PDT, dynamically monitoring
its concentration in real-time with the novel NO probe CuFl. Simultaneously Ca2+
imaging, achieved with the widely used Ca2+ probe Fura-2, was also used to investigate
the association between Ca2+ and NO signals.
Experimental methods and materials used in imaging experiments are described in
chapter 2, where a new method to accurately analyze CuFl fluorescence is introduced,
allowing the observation of real-time NO dynamics.
Our data, presented in the first section of chapter 3, provides the first direct ev-
idence of NO involvement in PDT. Moreover, simultaneous imaging shows the NO
signals in bystander cells spatially and temporally associated to an intercellular Ca2+
wave. The shape of NO signals suggests a dual mechanism that involves direct release
from the target cell as well as enzymatic production.
In the second section of chapter 3 we develop a mathematical model of NO diffusion
from target to bystander cells, in order to estimate the contribution of the diffusive
component relative to the enzymatic production. Afterwards, we introduce a compre-
hensive description of NO production from NOS caused by Ca2+ transients, that could
be divided in two major steps: the activation of the enzyme and the NO synthesis pro-
cess. For the latter we refer to previously reported models whereas for Cas+ mediated
activation of the enzyme we present a new mathematical description based on experi-
mental data reported in literature. The reliability of the overall model was tested by
comparing significant parameters predicted by simulations with corresponding values
found in literature.
The final goal of this study was to use our model of eNOS activation to predict NO
production rate in response to Ca2+ signals recorded in PDT experiments. Results are
shown at the end of chapter 3 and suggest that this model of eNOS activation and NO
production accounts for the rapid NO production caused by PDT, but fails to predict
subsequent enzyme inactivation. These results also suggest that local Ca2+ dynamic
is crucial to modulate NO production.
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Chapter 2
Experimental Methods and
Materials
2.1 Cell culture
C26GM mouse colon carcinoma cells line, previously described by Bronte et al.[16],
were grown in DMEM (Invitrogen), supplemented with 2mM L-glutamine, 10mM
HEPES, 50 µM 2-Mercaptoethanol, 150 U/mL streptomycin, 200 U/mL penicillin,
and 10% heat-inactivated FBS (Gibco). For in vitro studies, 1.5-2.0 x 105 C26GM
were plated on 12mm round glass coverslips into 24-well culture plates.
2.2 In vitro PDT, ratiometric calcium imaging and NO
imaging
Aluminum phthalocyanine chloride (AlPC) (Sigma) was dissolved in dimethyl sulfoxide
(Sigma) at (10 mM) and kept in the dark. C26GM cell cultures were incubated with
AlPC (10 µM) and co-loaded with Fura-2 AM (15 µM) (Molecular Probes) for 60 min at
37° in DMEM containing pluronic F-127 (0.01%, w/v), and sulphinpyrazone (250 µM).
For NO detection, after one hour of AlPC and Fura-2 incubation, cells were loaded with
CuFl (20 µM) for 20 min at room temperature. C26GM cells were then transferred
to the stage of an upright spinning-disk confocal fluorescence microscope and continu-
ally superfused with an extracellular medium containing NaCl (150mM), KCl (5mM),
MgCl2 (1mM), Sodium Pyruvate (2mM), Hepes-NaOH (10mM), D-glucose (5mM) (pH
7.2, 310 mOsm). When present, CaCl2 was added at the final concentration of (1mM).
For focal photosensitization, the output of a 671nm solid state laser was injected
into a permissive fibre optic cable (62.5 µm core, Thorlabs), whose output was pro-
jected onto the specimen plane by an aspheric condenser lens (20 mm effective focal
length, Thorlabs) and the recollimated beam was directed onto a dichromatic mirror
(650 shortpass, Edmund Optics) placed at 45° just above the objective lens of the mi-
croscope. By carefully adjusting the position of the fiber in front of the aspheric lens
we projected a sharp image of the illuminated fiber core (spot) onto the specimen focal
plane selected by the objective. For focal PDT treatment, an irradiation time of 60 sec
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was used to deliver 0.06 mW/µm2 of light (Power = 5 mW centered on a circular area
of 80 µm2) from the 671 nm solid state laser, using a 40X water immersion objective
(N.A.= 1.15, UApoN340, Olympus).
Fura-2 fluorescence was alternatively excited at 365 nm and 385 nm by light
from collimated high power LEDs(M365L and M385L, respectively; Thorlabs) filtered
though 15 nm interference band-pass filters and directed onto the sample through a
DM480HQ dichromatic mirror (Olympus). Fluorescence emission was selected using
an interference filter (BA495-540HQ, Olympus) to form fluorescence images on a sC-
MOS camera (PCO.Edge). Images were recorded on at a rate of 1 frame pair per
second. Signals were measured as dye emission ratio changes, △R = R(t) − R(0),
where t is time and R(t) is emission intensity excited at 365 nm divided by the inten-
sity excited at 385 nm, and R(0) indicates pre-stimulus ratio. Estimates of [Ca2+]c
were made from ratio values by application of the Grynkiewicz equation[37]
[Ca2+]c =
kd(R−Rmin)
Rmax −R
(
Ff
Fb
)
(2.1)
Symbol definition and details on fluorescence Ca2+ imaging based on dual wavelength
indicators are provided in appendix B on page 61. Calibration procedure and details
are described in the next section.
For NO detection, after one hour AlPC incubation, cells were loaded with the novel
selective fluorescent probe, 2-4,5-Bis[(6-(2-ethoxy-2-oxoethoxy) -2-methylquinolin-8-
ylamino)methyl] -6-hydoxy-3-oxo-3H-xanthen-9-yl benzoic acid Fl5 (CuFl)[58] at the
final concentration of (20 µM) (Strem Chemicals). Cells co-loaded with AlPC, CuFl
(and eventually also Fura-2 for combined imaging experiments) were excited using a
collimated 470 nm LED (M470L2–C1, Thorlabs). Signals were measured as relative
changes of fluorescence emission intensity (△F/F0), where F0 is prestimulus fluores-
cence, F is fluorescence at post–stimulus time t and △F = F–F0. Since CuFl is an
irreversible fluorescent indicator an estimate of NO concentration can be be derived
from the temporal derivative of relative changes in fluorescence emission:
[NO](t) ≃
d
dt
(
F (t)
F0
)
kfluo
(
13.14 −
F (t)
F0
) (2.2)
as described in section 2.4 on the facing page.
Images were recorded at a rate of 1 couple of frame/second for Fura-2 and 1
frame/second for CuFl, (camera exposure time 50ms/frame). Pharmacological in-
terference experiments with EGTA (100µM) (adjusted to pH 7.3 with NaOH), U73122
(2.5µM) and Flufenamic Acid(FFA) (100µM), Probenecid(200µM), 2-APB(100µM),
Suramine (200µM) and CBX(100µM) were performed by adding the reagents in ex-
tracellular medium bath at room temperature.
In order to assess possible direct effects of AlPc or its photo-activation by-products
on Fura-2 or CuFl fluorescence emission, experimental tests were carried on in small
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aqueous vesicles dipersed in Sylgard[19]. In these conditions, AlPc photo-activation did
not induce changes in CuFl fluorescence emission and caused a negligible increase in
Fura-2 emission both at 360nm and 380nm excitation wavelengths. Details are shown
in section C.2 on page 64.
2.3 Time-lapse microscopy of apoptosis triggered by focal
PDT with AlPC
C26GM cell were co-loaded with AlPC and fura-2 as described above. After focal
(single cell) photosensitization, pSIVA-IANBD and Propidium Iodide (Imgenex) were
added directly to the extracellular medium enriched with CaCl2 to the final concen-
tration of (2.5 mM) and cells were imaged by time-lapse microscopy for up to 4 hours.
pSIVA-IANBD fluorescence was excited at 470 nm and fluorescence emission was se-
lected using an interference filter. Propidium Iodide was illuminated by a 535 nm
LED, through a DM560 dichromatic mirror (Olympus), and fluorescence emission was
collected through a long-pass emission filter (590LPV2, Olympus).
2.4 CuFl fluorescence emission
CuFl is a novel turn-on fluorescent cell-permeable probe designed to visualize NO in
living cells. Unlike previously reported NO fluorescent sensors, CuFl directly and im-
mediately images NO rather than its derivative species and it can spatially distinguish
which cells are producing NO. This highly sensitive proble can yield a fluorescence
increase up to 16-fold in the presence of excess NO[59]. The fluorescence response of
CuFl to other reactive species is negligible, with the relevant exceptions of ONOO−
and O−2 which cause a fluorescence increase of 2.6-fold and 2-fold respectively (figure
2.1 (b)).
The mechanism responsible for NO sensing by CuFl is based on the coordination
of a fluorophore ligand to a metal ion to quench the fluorescence, which is restored by
NO reduction of the metal center with release of the nitrosated ligand. This process
occurs irreversibly[58][69] and is described by the following reaction scheme[59]:
Fl + CuII ←→ CuII(Fl) (2.3)
CuII(Fl) + NO −−→ CuI + FlNO (2.4)
With reference to our experimental setup configuration, CuFl fluorescence emission
was collected in the range from 500 nm to 540nm, resulting in an effective 14.14 fold
emission increase. Fluorescence emission of CuFl can be related to the fluorophore
concentration by means of the proportionality constant S. Therefore the total emission
recorded at every instant is:
F (t) = S[CuFl](t) + 14.14S[FlNO](t) (2.5)
Let us define F0 as fluorescence emission at time t0, the time in which the experiment
data recording starts. At such time a small fraction of loaded CuFl already reacted
13
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(a) (b)
Figure 2.1: (a) Fluorescence emission spectra of a solution of CuFl upon addition of NO (1.3
mM) (b)Specificity of CuFl for NO over other species. All data are normalized with respect to
the emission of CuFl (Reproduced from Ref.[59]).
with NO giving rise to FlNO, therefore the fluorescence emission is due to both species
but the latter results negligible:
F0 = S[CuFl](t0) + 14.14S[FlNO](t0) ≃ S[CuFl](t0) (2.6)
and the normalized fluorescence emission results
F (t)
F0
= 1 + 13.14
[FlNO](t)
[CuFl](t0)
(2.7)
Given that the reaction between NO and CuFl occurs irreversibly, fluorescence emission
at a particular instant does not directly represent NO concentration. However it is
possible to relate such concentration to the rate of increase of fluorescence signal.
Indeed, consistently with reaction 2.4, the rate of Fl5−NO formation is:
d[FlNO](t)
dt
= kfluo[NO](t)[CuFl](t) = kfluo[NO] ([CuFl](t0)− [FlNO]) (2.8)
where the rate constant kfluo of the reaction has been introduced. Similarly we could
calculate the derivative of the normalized fluorescence emission:
d
dt
(
F (t)
F0
)
= 13.14
kfluo[NO](t)[CuFl](t)
[CuFl](t0)
(2.9)
and obtain an estimate of NO concentration through the last relation:
[NO](t) =
d
dt
(
F (t)
F0
)
kfluo
(
13.14 −
F (t)
F0
) (2.10)
In order to estimate NO concentration the value of the rate constant kfluor should
be known. Unfortunately such value has not been reported in literature yet, therefore
NO concentration presented in this work will be expressed as [NO]kfluor.
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2.4.1 Numerical analysis of CuFl data
In order to estimate NO concentration from raw fluorescence data, equation 2.10 must
be evaluated, particularly numerical differentiation of fluorescence data series is the
critical computation step.
Assuming that we can model recorded data F as the superposition of real fluores-
cence values F˜ with a white noise term gives:
F (ti)
F (t0)
=
F˜ (ti)
F˜ (t0)
+N(0, σ) (2.11)
where we have normalized our data to fluorescence emission at t0, estimated as the
mean fluorescence emission during the first ten seconds of recording.
Facing the task of numerical differentiate a data series, one could be tempted to
use a local method like simple finite difference:
dF
dt
≃
F (ti+1)− F (ti−1)
2δt
but such procedure greatly amplify noise on derivative estimates that results σ√
2δt
.
Widely used procedures to avoid noise amplification are the so called global meth-
ods[47]. Such methods yield an estimation f(t) of the data on the whole time interval
by means of least square minimization and then analytically differentiate it.
In practice recorded data was divided in two dataset, the first one consist of signal
baseline until photoactivation that take place at 30s, the second from photoactivation
to the end of recording. Both samples were interpolated with a least square polynomial
of order N1 and N2, setted to N1 = 2 for the first dataset and N2 = 10 for the second
one in order to reduce noise without originate artefacts. The interpolating polynomial
in the second data set was also constrained to be continuous with the first one.
2.5 Data analysis and statistics
Images, acquired using software developed by Prof. Mammano’s group, were analyzed
based on Matlab platform (Release 14, MathWorks, Inc., Natick, MA, USA). Specific
regions of interest (ROIs), corresponding to different cells located at different distance
from the PDT-targeted cell, were drawn in order to measure the mean fluorescence
traces of Fura-2 and CuFl signals per single cell obtained as the mean fluorescence
value on every ROIs area at every instant. Specifically, for statistical analysis of the
bystander effect, we have selected an annulus, centred on the target cell, with an inner
radius of 75 µm and an outer radius of 120 µm. In such region 36 randomly selected
cells were considered.
In order to compare different experiments and drugs effects the amplitude of Ca2+
and NO signals in the annular region and the Ca2+ wave speed were chosen as the
most significant parameters. Amplitude was measured as maximal Ca2+ or NO con-
centration variation in response to a specific stimulus. Unless otherwise stated, statis-
tical comparisons of means for paired samples were made by one-way heteroscedastic
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Student t-test. p-values are indicated by letter p and p< 0.05 was selected as the cri-
terion for statistical significance. In figures, asterisks were used as follows: * p≤0.05;
**p≤0.01; *** p≤0.001.
Pseudocolor images were generated using the hue-saturation-value (HSV) visual-
ization algorithm: hue was used to represent fluorescence changes; value (brightness)
carried pixel intensity from a reference image that was either updated on a frame-by-
frame basis or obtained as an average over a specified number of frames; saturation
was set to 1.0. Frames so constructed were converted to ordinary RGB images by a
single call to the Matlab library function hsv2rgb, and displayed.
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Results
3.1 Experimental Results
3.1.1 Calcium and Nitric Oxide: bystander signals in PDT
Radiation induced bystander effects have become established in the radio-biology vo-
cabulary but key messengers and signalling pathways are only partially characterized.
Several reports suggest the involvement of NO and RNS in bystander effects, even if
no direct evidence of NO release after PDT has been published. Chemiluminescence
and spectroscopy have been used for NO tracking, however these methods suffer from
low spatial and temporal resolution and, in some cases, require complicated instru-
mentation.
Small molecule–based fluorescent probes for NO, including o-diaminonaphthalene
(DAN), o-diaminofluoresceins (DAFs) and o-diaminocyanines (DACs), are now com-
mercially available, but their changes in fluorescence require reactions with oxidized
NO products rather than NO itself, thus, their fluorescence-response does not necessar-
ily reflect real-time NO production. For these reasons, we based our studies on CuFl
that is substantially more selective for NO compared to other potentially interfering
molecules and can be utilized to visualize NO production in living cells with a high
spatial and temporal resolution[58].
To single out the key mediators of bystander effects and to define the role of NO,
imaging experiments were performed on C26GM colon cancer cell monolayers grown on
glass coverslips and co-loaded with the PS AlPC. Drug photoactivation was restricted
to a single cell of the culture by focusing 670nm laser light into an 80 µm2 circular
area. We refer to this type of stimulation as focal PDT (fPDT).
Since NOS activation may depend on intracellular Ca2+ concentration, which is
known to modulate a plethora of cellular processes and is also involved in cell death,
we took advantage of the ratiometric Ca2+ indicator Fura-2 to monitor intracellular
Ca2+ level variations.
As shown in figures 3.1 and 3.2, fPDT evoked a rapid increase in intracellular
Ca2+ concentration and induce a Ca2+ wave that propagates from target cell invading
the whole field of view (corresponding to an area of 6 · 104µm2). Simultaneously,
an extremely fast NO release from target and bystander cells is observed. These
17
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Figure 3.1: Representative false-color images of Ca2+ and NO concentration during PDT in
control C26GM cells, encoded as shown in the color scale bar. NO signals were expressed as a
function of kfluo(see methods). Images illustrate the sample before 1-min AlPc photoactivation
and after +2, +5 and +10 s from laser turn on.
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Figure 3.2: NO and Ca2+ traces obtained within 7 regions of interest (ROIs) corresponding
to individual cells at increasing distance from the irradiated one, as shown in the first frame
of figure 3.1
data provide the first direct evidence that fPDT induce NO release from irradiated
as well as non-irradiated cells, which may release ions, cytokines and other second
messengers establishing a signalling intercellular network responsible for bystander
effect in tumors.
Moreover these data support the notion that bystander cells actively participate
in the spreading of the PDT response, as intracellular Ca2+ and NO production may
be detected also at distant site from the target cell. The mechanism underpinning
the crosstalk of this signalling network, however require further investigation. Thus,
we have selected three parameters that characterize the observed signal patterns: the
maximal concentration variation of Ca2+ and NO in bystander cells located in an
annular region centred on the target cell -with an inner radius of 75µm and an outer
radius of 120 µm- and the speed of Ca2+ wave computed by linear interpolation of
time to half-maximum versus distance from target cell.
These data also provide a completely new insight in NO release modality during
PDT. In fact, the shape of recorded NO signals in target cell, that show an extremely
rapid concentration increase followed by an exponential decay, suggests a double mech-
anism in which, on one hand, NO is directly released from target cell and diffuse to
bystander cells during the first seconds of photosensitization. Then, high NO levels
in bystander cells are maintained even after central source depletion, suggesting NO
enzymatic production in these cells. Moreover, fast NO release from target cell is in
agreement with the reported capability of AlPc to buffer NO and the hypothesis of
NO release during the PS oxidation, which might take place following photoactivation.
Therefore, we could temporally distinguish two phases in PDT-induced NO signalling:
a first one, lasting for few seconds in which diffusion dominated and a second one that
is found to be primarily enzymatic dependent, as highlighted in figure 3.3.
NO production evoked by PDT raised the hypothesis that NO might be the prod-
uct of NOS enzymes triggered by intracellular Ca2+ transients. Only constitutive
eNOS and nNOS activity is considered CaM/Ca2+ dependent. However several re-
ports demonstrated iNOS positivity in human tumor samples, including colon cancers.
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Therefore we performed mRNA analysis to identify the NOS isoforms expressed by
the C26GM cell line. We detected low absolute mRNA levels of all three isoforms
(particularly low in the case of iNOS) and the highest signal corresponded eNOS.
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Figure 3.3: NO traces obtained within 7 regions of interest (ROIs) corresponding to individual
cells at increasing distance from the irradiated one. PDT-induced NO signalling shows a two
phases mechanism with a first diffusion dominated phase followed by a production dominated
one.
3.1.2 Photodinamic Therapy and cell death
Both Ca2+ and NO are reported to be involved in the induction of apoptosis. In-
deed, the loss of Ca2+ homeostasis may lead to cell injury as well as high levels of
NO/RNS which, through modifications of death-related target proteins, mediate in-
hibition of cellular respiration, thus affecting mitochondrial membrane permeability,
finally leading to cytochrome c release and initiation of apoptosis[53]. PDT has been
indeed demonstrated to trigger both apoptosis and necrosis[75]. Thus, we performed
fPDT with AlPc and we evaluated the expression of specific apoptotic markers. In
particular, we used pSIVA, an annexin-based, polarity sensitive probe for the spatio-
temporal or kinetic analysis of apoptosis [30]. In these experiments, we monitored only
Ca2+ (with fura-2) and not NO due to the overlap between CuFl and Psiva fluores-
cence emission spectra. After fPDT, we added pSIVA and propidium iodide (PI) to
the extracellular medium. Fluorescence images were acquired every 30 min (1 frame
for pSIVA and 1 frame for PI). The irradiated cell displayed a clearly detectable pSIVA
signal afters 30 min (data non shown). Within 1 hour following PDT, both pSIVA and
PI signals were detected in the irradiated cell and its nearest neighbours; thereafter
the signals propagated to more remotely located bystander cells(Figure 3.4). By 4
hours about 40% of cells in the field has at least entered apoptotic cell death. No toxic
effects were observed in control experiment, in which the PS AlPC was loaded but not
20
3.1 – Experimental Results
Figure 3.4: Photosensitization induces an “apoptotic death-wave”. a. Representative
false–color images of Fura-2 fluorescence ratio variation during fPDT in AlPC-treated C26GM
cells either non-photostimulated (ctrl) or photosensitized (PDT). Ca2+ level variation is en-
coded as shown by the color scale bar. Time-lapse microscopy was used to monitor apoptosis
by real-time detection of phosphatidylserine externalization in C26GM cells subjected or not
to fPDT. Representative color-merged images of C26GM cells; propidium iodide fluorescence
(red) and pSIVA fluorescence (green) at the indicated time (h, hours) following or not fPDT. As
an apoptosis positive-control, cells were incubated with Staurosporine (e, upper image).Scale
bars, 50 µm.
photoactivated. These data demonstrate that unless photostimulated, the PS is not
able to trigger any Ca2+ wave. As internal positive control of the staining, control
cells were treated with staurosporine, a well known apoptosis inducer(20 µM, 2 hour
incubation) after 4 hours of recording (Figure3.4e). Altogether, these results support
the notion that fPDT promotes bystander cell death and suggest that these effects
may contribute significantly to the efficacy of PDT in cancer treatment.
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3.1.3 Pharmacological interference experiments
In order to better characterize the temporal association among intracellular Ca2+ con-
centration variation and NO signals, we performed pharmacological interference exper-
iments with different drugs modulating different key components of the Ca2+ signalling
toolkit. Primarily, we performed the same fPDT experiments in Ca2+ free extracellu-
lar medium (supplemented with the Ca2+ chelator EGTA) to evaluate the relevance
of Ca2+ influx from extracellular milieu; moreover, we exploited the phospholipase C
inhibitor U73122 to reduce the amount of intracellular IP3 and consequently Ca
2+
release from the intracellular stores. Aiming at identifying the molecular mechanisms
responsible for Ca2+ wave propagation we repeated fPDT experiments by blocking
connexin based channels, both gap junctions and connexin hemichannels by the use
of the specific inhibitors CBX, FFA and 2-APB [6]. Taken together these data sug-
gest that IP3 mediated Ca
2+ release from intracellular stores is instrumental for the
spreading of PDT response. Furthermore, gap junction channels play a key role in
propagating PDT induced Ca2+ waves as well as NO signals in bystander cells.
Since ATP, which might be released by apoptotic cells through pannexin chan-
nels[33], thus activating purinergic receptors expressed on nearby cells surface, could
promote Ca2+ wave propagation, we tested also the impact of pannexin blockage by
Probenecid or aspecific purinergic receptors inhibition by Suramine in fPDT induced
bystander signals.
Figure 3.5: Role of pannexin hemichannels and purinergic receptors in the propagation of
Ca2+ signals (reproduced from [8]). The released ATP would interact with metabotropic
purinergic receptors (P2Y, blue), bringing about the production of the second messenger IP3
(green circles), which induces Ca2+ release from the ER. Either IP3 or a Ca
2+-dependent
process would then trigger the opening of Panx1 hemichannels, ensuring the release of ATP
and the transmission of a Ca2+ wave.
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Figure 3.6: Pharmacological interference in fPDT experiments with different drugs (see meth-
ods for details). Maximal variation of Ca2+ concentration expressed in µM and NO levels,
expressed as percentage of control average levels, (∆Ca2+ and ∆NO) were measured in 36
randomly selected cells between 75 µm and 120 µm from target cell. For each drug reported
values represent an average on three independent experiments.
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3.2 Mathematical model of Bystander Effects
As we have seen, fPDT induces Ca2+ transients and NO signals in neighbouring cells,
spreading at great distances from target cell, taking account of bystander effect.
The task of this section is to develop a mathematical model of this signalling
patterns capable of giving us a better comprehension of the molecular mechanisms
underlying bystander effect in PDT, with particular reference to NO signals.
As we already stressed, the pattern of NO signal propagation shows a diffusive
contribute from a central source and also a production contribution likely due to eNOS
activation follows Ca2+ wave propagation. So we introduced a simple diffusive model
in which NO is released from target cell and diffuse to bystander cells. As we are going
to see, such approach allows to single out enzymatic production of NO. In order to
describe the enzymatic contribution to NO signals we have developed a model, based
on an extensive literature study, to quantitatively describe NO production by eNOS
and eNOS activation by Ca2+ through CaM. Neither the enzymatic process catalysed
by eNOS nor eNOS binding kinetics to CaM are completely clear so a few hypotheses
are going to be introduced. Significative parameters, like enzyme activity and half
maximal effective concentrations (EC50) for Ca
2+, were also predicted and compared
with reported values, in order to test the reliability of the model.
3.2.1 Diffusive Bystander Effects
Nitric Oxide chemistry and lifetime
The reaction chemistry of NO is complex due the instability of most of its reaction
products. In particular, NO lifetime in a real tissue or simply in the presence of
cells, is a complex matter because enzymatic process involving NO, protein nitrosation
and NO localization in hydrophobic regions have significative effects. NO lifetime in
physiological conditions spread from few milliseconds to few seconds depending on
oxygen concentration and tissues properties[96].
In order to obtain a complete overview of possible biological effects of NO and the
factors that influence its lifetime, is useful to systematically analyze its chemistry. The
reaction pathways involving NO are complex for two reasons, the first one is that it
is thermodynamically unstable, the second is that most of its oxides have an unstable
electronic structure[32]. NO itself, in condition of high pressure and temperature, can
directly dismutate via the pathways:
3NO −−→ N2O+NO2 (3.1)
2NO −−→ N2 +O2 (3.2)
NO can also be oxidized to the nitrosonium cation NO+ through the reaction:
NO −−→ NO+ + e− (3.3)
Reaction potential of −1.21 V, needed for the oxidation, exceeds range of typical
reaction potentials found in vivo so its production in biological context is probably due
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to heterolytic fission of N2O4. Even when formed, nitrosonium has a short lifetime in
water because, in physiolgical pH range, the reaction:
NO−2 + 2H
+ ←→ NO+ +H2O (3.4)
is heavily shift to the left side[51]. Alternatively NO can be reduced to the nitroxyl
anion NO−, isoelectronic to O2, that may exist in a spin triplet or singlet state as
dioxygen. Triplet ground state 3NO− can be protonated to HNO and then irreversibly
decomposed to N2O .
At low concentration as in biological situation, the reactions 3.2 result inhibited
but NO2, that take on an important part in biological sample due to its role in generate
nitrosating agents, may be formed by not yet clarified reactions with dioxygen for wich
two different pathways has been proposed. Both pathways have a net balance
2NO +O2 −−→ 2NO2 (3.5)
After 2NO2 radical production the appearance of nitrostaing species like N2O4
and N2O3 occurs. These species are highly reactive and most important for biological
system because together with NO+ are the only compounds with proven ability of
S-nitrosation[32]. The nitrosation reactions are fast processes that transform a thiol
group RSH to a nitrosothiol RSNO
N2O4 +RSH −−→ NO
−
3 +RS-NO +H
+ (3.6)
N2O3 +RSH −−→ NO
−
2 +RS-NO +H
+ (3.7)
These nitrosation processes are so fast that dominate, at physiological thiol concen-
trations, even if in competition with hydrolysis to nitrite or nitrate, according to the
reactions
N2O4 +H20 −−→ NO
−
2 +NO
−
3 + 2H
+ (3.8)
N2O3 +H2O −−→ 2NO
−
2 + 2H
+ (3.9)
The balance of above reactions produces nitrite with a third order reaction
d
dt
[NO−2 ] = k[·NO][O2] (3.10)
and a rate k = 5 ∗ 10−6 M−2 s−1[29]. The low rate of this reaction guarantees that
uncatalyzed oxidation of NO through above reactions doesn’t affect significantly NO
lifetime. Even at full O2 concentration of hundreds of µM, such value implies a lifetime
of many hours in aqueous solution.
However is clear that in biological systems the situation is more complex, first of
all the heterogeneous structure with regions of low polarity give raise to local higher
concentration of NO significantly accelerating autooxidation up to 300-fold[61], further-
more, NO consumption by enzymatic pathways, such that involving oxyhemoproteins
and superoxide, could also take place.
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In fully oxygenated blood the dominant heme species is α(FeO2)2 − β(FeO2)2 which
rapidly oxidizes NO to nitrate with a high reaction rate of k ∼ 1 ∗ 107 M−1 s−1 and is
the dominant NO loss in the vasculature in which NO lifetime can reach τ ∼ 2 ms[96].
A higher reaction rate applies to the reaction with superoxide radical, also produced
during PDT, that produce peroxynitrite. This is a diffusion limited reaction with
reported rates between 4.3 ∗ 109 to 1.9 ∗ 1010 M−1 s−1. Peroxynitrite is a powerful
oxidizing agent and could be highly damaging to cellular processes reacting with the
metal containing site of many enzymes. Hemoprotein in particular, like hemoglobine,
cytochromes and NOSs, are prone to modification by peroxynitrite that inhibit their
catalytic activity.
These studies show how complex NO chemistry is in biological system, with dif-
ferences in NO consumption between intracellular and extracellular medium and also
between different subcellular structures. In the absence of really detailed information
about this environment a simpler description is needed. As shown by Lancaster et
al, analysing NO consumption in a cells suspension, these complex reaction pathways
can be efficiently approximated by a simpler kinetics law that relates NO loss to O2
concentration and cell density:
d[NO]
dt
= −kobs[O2][NO][Cell] (3.11)
where [Cell] is numeric cells concentration and a value of 5.38 ± 0.3 ∗ 10−4 M−1s−1 (
cell/ml )−1 for kobs for hepatocytes is reported [96].
Nitric Oxide diffusion
In order to describe the diffusive contribution to NO bystander signals, we consider
a simple model in which NO buffered by AlPc and eventually heme-proteins, is re-
lease during photoactivation and diffuse to neighbouring bystander cells. A common
assumption founded in literature is the ability of NO to freely diffuse across cell mem-
branes due to its small molecular weight and neutral charge[65][38]. Such assumption
allows to mediate the effects of reactions that take place in extracellular or intracellu-
lar milieu leading to a simplified description of NO chemistry, in which all previously
described reactions are summarized by a single effective degradation constant kdeg that
could depend on O2 and cell concentrations. In such conditions NO concentration is
determined by:
d[NO](r, t)
dt
= DNO∇
2[NO](r, t)− kdeg[NO](r, t) (3.12)
where DNO = 3300 µm
2s−1 is the diffusion coefficient for NO.
Sucessive investigations pointed out that NO diffusion coefficient is highly reduced
in lipophilic media, like biomembranes and lipoproteins[73] [62]. Accordingly to these
facts, it was recently reported that cell membrane represents a significant diffusion bar-
rier for NO transfer and diffusion through cell membranes requires specific connexin-
based channels[109]. Following such model we need to distinguish between NO con-
centration in the extracellular space [NO]ex and in the cytoplasm [NO]in. In the
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extracellular space NO can freely diffuse and the degradation term could be neglected
as follows from previously described NO reactions in water. Intracellular NO concen-
tration is influenced by NO influx from connexin-based channels and a degradation
term that summarize NO consumption by previously described processes. The flux of
NO between extracellular and intracellular space was assumed to be proportional to
the difference of NO concentration between them. Therefore [NO]ex and [NO]in are
determined by:
d[NO]ex(r, t)
dt
= DNO∇
2[NO]ex(r, t) +
N∑
j=1
khc ([NO]in,j − 〈[NO]ex(r, t)〉j) (3.13)
d[NO]in,j
dt
= khc (〈[NO]ex(r, t)〉j − [NO]in,j)− kdeg,in[NO]in,j (3.14)
where [NO]in,j is NO cytoplasm concentration for cell j, khc represents the hemichannel
transfer rate that depends on the number of channels and their unitary permeability,
kdeg,in is the intracellular effective degradation constant and 〈[NO]ex(r, t)〉j represents
NO extracellular concentration in proximity of cell j.
This model for NO diffusion is also supported by our experimental results: indeed
the amplitude of NO signals in groups of bystander cells selected at fixed distances from
the target cell, turn out to be heterogeneous. Such variability strengthens the hypoth-
esis of connexin involvement in NO spread, because the hemichannel transfer rate
depends on the variable number of channels expressed in every cell. Moreover, experi-
ments carried out in our lab with the partially selective pannexin blocker Probenecid,
shows a strong reduction in the amplitude of NO signals without decisively affect
the amplitude of Ca2+ signals. This result suggests that hemichannels-blocking can
prevent NO influx from extracellular space, confirming connexin channel role in NO
trafficking.
Equations 3.13 and 3.14 were solved with a simple finite difference approach with
a timestep ∆t = 50 µs. The domain in which the equations were solved and the
corresponding boundaries conditions are illustrated in figure 3.7. The domain volume
was discretized with a step size of 10 µm in the z direction and 2 µm in the x and
y directions. Cells were modelled as polygons reproducing experimental distribution
located at z = 0 µm, while a reflecting boundary at z = −10 µm describe the effect
of underlying glass. Finally, absorbing boundaries were considered at z = 150 µm and
in correspondence of x and y limits at +300 µm and −300 µM. The algorithm was
implemented with python, taking advantage of Scipy library and particularly sparse
matrices modules[44].
Our algorithm was tested solving eq. 3.12 for different diffusion coefficient values
because in such cases an analytical solution can be derived for a point source situated
in the origin. The analytical solution of eq.3.12 with a reflecting boundary at zb, for
an impulsive initial condition in the origin [NO](r, t0) = δ(r) results:
[NO](r, t) =
1
(4piDNOt)3/2
e
− x
2+y2
4DNOt e−kt
(
e
− z2
4DNOt + e
− (zb−z)
2
4DNOt
)
(3.15)
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Figure 3.7: Scheme of model geometry and boundaries
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Figure 3.8: Analytical and numerical solution of eq.3.12 for an impulsive initial conditions
in the origin, computed at z = 0.
The comparison of analytical and numerical solution of eq. 3.12 is show in figure
3.8.
Therefore eq. 3.13 and 3.14 were solved in order to reproduce the diffusive com-
ponent of NO bystander signals. In such simulations, the measured NO concentration
in target cell was used as an additional boundary condition for the model. Naturally,
NO increase in bystander cells due to diffusion from the central source, depends on
kdeg,in and khc. For the first parameter, possible values ranges from 10 s
−1 to less than
0.5 s−1, corresponding to reported extravascular half-life of NO from 0.09 to > 2 s[96].
Like Ca2+ or IP3 influx through gap junctions, transfer rate khc will be proportional
to the number of channels and their unitary permeability, and inversely proportional
to cell volume[39]. No values were reported in literature yet, so a wide range of khc
values was tested.
Our results, illustrated in figure 3.9 highlight that NO level in bystander cells are
weakly affected from parameter changes when khc exceed 5 s
−1 or kdeg,in is above 0.5
s−1. Unfortunately we could not access the real values of those parameters, however
in the aim of highlight the involvement of NO enzymatic production in fPDT we could
consider threshold values in which the diffusive contribution to NO levels in bystander
cells is maximum. Evaluating the differences between experimental values and pre-
dicted maximal diffusive contributions, give us a minimal estimate of the production
term, its time-course and its amplitude relative to the central source. The resulting
production components are shown in figure 3.10.
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Figure 3.9: Simulations of NO levels in bystander cells, selected at increasing distance from
the photoactivation spot, due to NO release from target cell (black data points), for different
khc and kdeg,in values.
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Figure 3.10: (a) NO signals evoked by fPDT whitin 5 ROIs at increasing distance from
target cell, compared with the diffusive components due to NO release from target cell. (b)
NO production components of PDT-evoked NO signals, obtained as the differences between
experimental data and NO levels predicted from simulation. khc = 5 s
−1 and kdeg,in = 0.5 s
−1.
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3.2.2 Enzymatic Nitric Oxide production
Nitric Oxide production rate
The biochemical pathway of NO production by NOS is a well studied enzymatic process
but the precise description of the NOS molecular mechanism is still lacking. Conse-
quently several models of NO production from NOS have been proposed in the last
years and all of them share a similar overall reaction scheme but differ in the num-
ber, origin and characteristics of the electron transfer processes that take place during
enzyme activity[88].
Global catalytic mechanism of NOS consists in two successive steps of oxidation
that collectively need one molecule of L-Arg, two molecules of O2, and three electrons.
In the first step hydroxylation of L-Arg to NOHA takes place. In the second step
NOHA acts as a substrate and is oxidized to L-Cit finally leading to the release of one
molecule of NO and two molecules of water. With reference to the global mechanism
illustrated in figure 3.11, the reaction starts with the oxidation of NADPH, that pro-
vide an electron through the NOS flavoprotein domain to ferric heme, reducing it to
the ferrous form. This is the slowest step of the biosynthetic reaction and leads to the
formation of ferric superoxide after O2 binding[105]. The tetrahydrobiopterin (H4B)
reduction is the second slowest step of the process but is sufficiently fast to prevent
superoxide release from ferrous heme group[21]. This step is one of the unique func-
tional features of NOS because of the redox role of H4B [88]. Another unique feature of
Figure 3.11: NO synthase global mechanism.[95]
this enzyme is its ability to achieve two different oxidative chemistries using the same
constrained active sites, effectively after the reduction of ferrous superoxide to ferric
oxide, the last one is rapidly protonated to form a heme iron-oxo species that may
react directly with L-Arg or NOHA[81]. Reaction with NOHA produce a ferric heme
NO complex(Fe3+NO) that only later dissociates releasing free NO[105]. Meanwhile
Fe3+NO can be reduced to Fe2+NO which release NO very slowly and is instead oxi-
dized by O2 to nitrate (NO
−
3 ), moreover NO can also bind to NOS in both its ferric
or ferrous oxidation states [90]. Consequently, after Fe3+NO biosynthesis is completed
two different cycles compete: direct NO release could be considered part of a ”pro-
ductive cycle” whether reduction of Fe3+NO guides the enzyme into a ”futile cycle”
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Table 3.1: Concentration of coenzymes and substrates required to reach 50% of NO produc-
tion and physiological concentration in different cell types. † The intracellular concentration
of L-Arg has been reported to be ∼100 µM in endothelial cells. However the L-Arg availability
to the enzyme is really lower due to the phenomenon known as the ”L-Arg paradox” probably
produced by the division of L-Arg in different pools or compartments[26][102].
EC50 Ref. Range Ref.
CaM 0.008 − 0.009 µM [60] [34] 2-25 µM [86] [14]
H4B 0.05 − 0.22 µM [60] [34] [78] ∼3.6 µM [70]
NADPH 1 µM [34] ∼166 µM [70]
L-Arg 0.9 − 2.9 µM [34] [107] ∼1-100 µM † [107]
O2 7.7 µM [84] 50-170 µM [98]
that at last produce nitrate instead of NO. Because of this mechanism the fraction of
enzyme occupied with futile cycle depends on NO concentration, introducing a neg-
ative feedback mechanism that can modulate enzyme activity. As previously shown,
the rate limiting step in NO synthesis is the reduction of ferric heme domain,which
is considerably slower than that of other flavoheme enzymes similar to NOS. This
peculiarity has a precise biological reason because increasing the reduction rate will
partition more NOS in the futile cycle and ultimately convert the enzyme in a NO
oxygenase[95]. Moreover, reaction rates are not the same for different NOS types, so
futile cycle and NO feedback mechanism could have different roles. Particularly, eNOS
is less sensitive to futile cycle mechanism [89].
In order to employ a Ca2+ to NO transduction model we have assumed the detailed
NO biosynthesis scheme proposed by Chen and Popel[23] described in figure 3.12. The
half maximal effective concentrations (EC50) for substrates and cofactors have been
reported by a variety of laboratories. A comparison between those values and physio-
logical concentration ranges in different cells is reported in table 3.1. Notably typical
intracellular concentration of H4B and NADPH are far larger than those required to
reach 50% catalytic activity. In order to simplify as much as possible our model, we
assumed that all coenzymes and NADPH were present in excess and ignored their
effects on the reaction pathway. Moreover we have included the binding kinetics of O2
and L-Arg but we have considered their consumption negligible or completely balanced
by external supply.
NO production mechanism shown in figure 3.12 was translated in a set of coupled
differential equations reported in appendix A, describing concentration of different
eNOS states, represented by the oxidation state of their heme group, and different
substrates and products.
Kinetic parameters of the model were found in literature and are listed in table
3.2. The experimental values were measured in vitro under various temperature, often
lower than in physiological condition. For this reason experimental measurements were
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Figure 3.12: NO synthase detailed mechanism, different eNOS states are labelled with the
oxidation state of their heme group. Reactions in boxes were considered fast and described as
single reactions[23].
scaled through Arrhenius equation to extrapolate the values at 37°C.
kT2 = kT1e
−Ea T1−T2RT1T2 (3.16)
where kT1 and kT2 are kinetic parameters at T1 and T2, R is the gas constant and
Ea the activation energy of the process. Activation energies are not known for these
processes, however several parameters have been measured at multiple temperatures,
allowing to estimate their activation energy and scale up kinetic parameters.
For those parameters measured only at one temperature some assumptions are needed.
As proposed by Chen and Popel[23], we have assumed that activation energy of those
steps when NOHA was bound to eNOS were the same as for the corresponding steps
when L-Arg is bound. Finally for ferric heme reduction, NO binding to ferric heme
and Fe3+NO oxidation, the activation energies were assumed to be the average of
all the available activation energies. We will refer to the activation energy of such
processes as Ea,r Side effects of this approximation were tested exploring the sensitivity
of the model to this parameter. However, it was reported that NO production rate
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Table 3.2: Kinetic parameters for eNOS, experimental values, predicted activation energies
and predicted parameter values at 37°C. Activation energies indicated by † were extrapolated
by similarities with other reaction steps whether values indicated by ⊙ were assumed to be the
average of all available activation energies. See text for details.
Parameter Values Ref. Value at 37°C Unit Ea[J/mol]
k1 0.2(4°C)− 0.8(23°C) [10] 1.99 µM
−1s−1 4.97 ∗ 104
k′1 0.08(4°C)− 1.6(23°C) [10] 11.50 s
−1 1.07 ∗ 105
k2 0.11(10°C) [89] 1.01 s
−1 6 ∗ 104⊙
k3 0.11(10°C) [89] 1.01 s
−1 6 ∗ 104⊙
k4 0.2(4°C)− 0.8(23°C) [10] µM
−1s−1 1.99 4.97 ∗ 104
k′4 0.08(4°C)− 1.6(23°C) [10] 11.50 s
−1 1.07 ∗ 105
k5 0.265(7°C)− 0.34(10°C) [1][66] 2.58 µM
−1s−1 5.47 ∗ 104
k′5 24(7°C)− 28(10°C) [1][66] 98.03 s
−1 3.38 ∗ 104
k6 6.2(7°C)− 6.7(10°C) [22][66] 12.59 s
−1 1.70 ∗ 104
k7 0.11(10°C) [89] 1.01 s
−1 6 ∗ 104⊙
k8 0.8(23°C) [36][10] 1.99 s
−1 4.97 ∗ 104†
k′8 1.6(23°C) [36] [10] 11.50 µM
−1s−1 1.07 ∗ 105†
k9 0.8(23°C) [36] [10] 1.99 s
−1 4.97 ∗ 104†
k′9 1.6(23°C) [36][10] 11.50 µM
−1s−1 1.07 ∗ 105†
k10 0.26(10°C) [1] 3.33 µM
−1s−1 5.47 ∗ 104†
k′10 18(10°C) [89] 89.86 s
−1 3.38 ∗ 104†
k11 14.5(7°C) [66] 29.43 s
−1 1.7 ∗ 104†
k12 0.11(10°C) [89] 1.01 s
−1 6 ∗ 104⊙
k13 0.00429(10°C) [89] 0.04 µM
−1s−1 6 ∗ 104⊙
k14 2.5(4°C)− 3.5(23°C) [89][66] 53.94 s
−1 7.39 ∗ 104
is negligibly affected when a single kinetic parameter is altered, with the exception of
the heme reduction rate[23].
We have used such model to predict the rate of NO production in a wide range
of conditions in order to study the sensitivity of NO production to the availability of
O2 and L-Arg and to temperature changes also. Model equations were solved using a
commercial software package (MATLAB 8.1, The MathWorks Inc., Natick, MA, 2013)
and the Matlab ODE suite. The initial conditions were set such that all eNOS was
in the ferric form, and L-Arg was not yet bound to eNOS. As shown in figure 3.13
(a) NO production reaches steady state in a few seconds. Enzyme concentration in
different cells could range from 0.001 to 0.01 µM [5][64]. In such interval, and also at
higher levels, NO production increased linearly with eNOS concentration as shown in
figure 3.13 (b). Thus an increase in enzyme concentration can greatly improve NO
production.
NO production rate increases rapidly with O2 and available L-Arg concentrations
until concentrations reach ∼ 5 µM and ∼ 10 µM respectively. Dependence of NO
production rate from O2 and L-Arg concentrations was explored in a large range of
values from 1 µM to 200 µM O2 and from 0.1 µM to 20 µM L-Arg at 25°C and 37°C,
typical temperatures of in vitro and in vivo experiments respectively.
Moreover, in order to compare our rate predictions with experimental results, we
have extrapolated from simulated data eNOS apparent activity A, that is maximum
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Figure 3.13: (a) NO production rate at 0.01, 0.05 and 0.1 µM eNOS concentration. (b)
Production rate at steady state linearly depends on eNOS concentration even at relatively
high enzyme concentration. Such results eventually allow to use a simplified Michaelis Menten
description also for high enzyme concentration. In both cases parameters value are: T = 37°C,
Arg= 10 µM and O2 = 100 µM
NO production rate per enzyme unit, by means of a simple double substrate enzyme
model:
eNOS+Arg eNOS-Arg + O2 eNOS-Arg-O2 eNOS+NO
Figure 3.14: Simple double substrates enzyme model with sequential binding.
Under usual Michaelis-Menten hypothesis, such as fast substrates equilibrium and
low enzyme concentration ([E] < [S1], [S2]), this simplified model predicts a rate of NO
biosynthesis at steady state of:
RNO =
A[eNOS]0
1 + A[Arg][O2]
+ B[Arg] +
C
[O2]
(3.17)
where A,B,C and A depend on kinetic constants of the process and [eNOS]0 is to-
tal enzyme concentration. Those parameters were evaluated by Least-Squares fit of
data obtained from the complete model. Residual analysis shows that the simplified
kinetics prediction does not precisely match data from complete model particularly
at T = 25°C, condition in which the great majority of our in vitro experiments were
carried on. First the hypothesis that the main contribution to this gap came from the
availability of the inactive enzyme state was explored. The inactive enzyme fraction
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at steady state was monitored over the same range of parameters and obtained values
were always lower than 0.003. Also removal of inactive state from complete model did
not produce appreciable changes in NO production rates so we rejected the hypothesis.
Probably the non Michaelis Menten kinetics of the process emerge from the particular
double cycle structure of the process. The scheme is also complicated by one irre-
versible step that occurs during NOHA synthesis, making impossible the application
of systematic analysis of the whole process by means of King diagrammatic theory or
later developments[49]. We have therefore empirically modified NO production expres-
sion from Michaelis Menten introducing higher order dependence on O2 concentration
in order to obtain a more detailed description of NO production and therefore a better
estimates of enzyme activity:
RNO =
A[eNOS0]
1 + A[Arg][O2]
+ B[Arg] +
C
[O2]
+ D
[O2]
2
(3.18)
where the parameter D was introduced. Least-Squares interpolation of the data
is shown in figure 3.16 and obtained parameters values are presented in table 3.3.
Apparent eNOS activity obtained at 25°C and 37°C were 0.19 s−1 and 0.48 s−1 re-
Table 3.3: eNOS apparent activity and parameters values for the empirically corrected
Michaelis Menten production kinetics.
T = 37C° T = 25°C Units
A 0.48 0.19 s−1
A 8.6 1.6 µM2
B 0.17 0.28 µM
C 6.7 4.9 µM
D −4.5 −2.7 µM2
spectively and are consistent with values reported by several groups for purified eNOS,
ranging from 0.04 s−1 [101] to 1.3 s−1 [60].
The activity of the enzyme is also a good parameter to evaluate the sensitivity
of the model to the unknown activation energy Ea,r that we have assumed to be the
average of all available activation energies. Figure 3.15 shows eNOS activity computed
for a wide range of Ea,r. Extreme values reported in literature for enzyme activity are
also highlighted. Enzyme activity is strongly affected by changes in this parameter
for which we could estimate a range of acceptable values between 2 kJ/mol and 100
kJ/mol.
Finally, we explored the NO production rate dependence from temperature in a
physiologically relevant range. Predicted rates increase from 0.005µM s−1 to 0.03µM
s−1 with a temperature increase from 15°C to 40°C.
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Figure 3.15: eNOS activity computed for a wide range of Ea,r values. Horizontal lines
highlight the range of activity values reported in literature.
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Figure 3.16: NO production at steady state predicted from complete model at T = 25°C and
interpolated with equation 3.18.
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Figure 3.17: NO production at steady state predicted from complete model at various tem-
peratures. Other parameters were set at typical physiological values [Arg] = 3 µM, [O2] = 100
µM and [eNOS] = 0.045 µM .
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NOS activation
Ca2+-dependent activation of eNOS and nNOS is mediated by the ubiquitous Ca2+
binding protein CaM. CaM is formed by two lobes that contain two E-F hands each
one capable of binding two Ca2+ ions in a cooperative way, providing on the whole
four Ca2+ binding sites. Importantly nNOS and eNOS can be activated only by fully
saturated CaM due to regulatory elements that characterize enzyme structure.
A key element of Ca2+ to NO transduction mechanism is therefore Ca2+ binding to
CaM. This process takes place independently at the N- and C-terminus of CaM where
two Ca2+ ions bind to the protein with different cooperative kinetics. Due to the fact
that each one of the four Ca2+ binding sites could be in a bound or unbound state, a
complete description of the system needs 16 independent variables. Since we are only
interested in saturated CaM concentration and different sites of the same terminal are
indistinguishable before the first ion is bound, we can consistently develop a simplified
description that only needs nine independent variables. We labelled each CaM state
in our model with the number of Ca2+ ions bound to N or C terminal and considered
all possible reactions. The resulting reactions network is shown in figure 3.18 whereas
detailed reactions at C and N terminal are shown in figure 3.19.
Figure 3.18: Ca2+-CaM binding scheme.
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Figure 3.19: Cooperative Ca2+ binding kinetics to CaM at N and C terminal. Factors 2 on
reaction rates were introduced considering indistinguishable different binding sites situated at
the same CaM terminal.
CaM+2Ca2+ CaM(Ca)1N+Ca
2+ CaM(Ca)2N
2 ∗ kN1
k′N1
kN2
2 ∗ k′N2
CaM+2Ca2+ CaM(Ca)1C+Ca
2+ CaM(Ca)2C
2 ∗ kC1
k′C1
kC2
2 ∗ k′C2
N-terminal reactions:
C-terminal reactions:
Table 3.4: Kinetics parameters of Ca2+ binding to CaM[31].
kN1 7.9 ∗ 10
8 M−1s−1
k′N1 1.6 ∗ 10
5 s−1
kN2 3.2 ∗ 10
10 M−1s−1
k′N2 2.0 ∗ 10
4 s−1
kC1 7.9 ∗ 10
7 M−1s−1
k′C1 2.5 ∗ 10
3 s−1
kC2 2.5 ∗ 10
7 M−1s−1
k′C2 15.8 s
−1
Rate constants of the process were recently measured monitoring Ca2+ dynamics
after rapid flash photolysis of caged Ca2+ in presence of CaM mutants. Resulting
parameters are shown in table 3.4 and characterize CaM as the fastest Ca2+ binding
proteins. As first suggested by Faas et al.[31], when intracellular Ca2+ increases, it
is rapidly buffered by CaM on a µs timescale and is then redistributed to slower but
more stable CaB. In details, simulation conducted starting from these data, showed
that within 40 µs after Ca2+ influx almost 80% of intracellular Ca2+ increase is bound
to CaM N-lobe. Later, after a few milliseconds, Ca2+ is redistributed between C-lobe
and other CaB. The overall mechanism is based on sequential binding events in which
Ca2+ is first caught by the fast but low affinity buffer CaM and then transferred to a
slow but high-affinity buffer.
CaM fast buffer mechanism is also influenced by CaM target proteins. Effectively
when Ca2+ saturated CaM is bound to eNOS, Ca2+ dissociation rate from CaM results
modified as we are going to see. In general, activation of CaM target proteins follow the
reaction scheme illustrated in figure 3.21. With reference to eNOS, we have previously
seen that CaM can bind the enzyme only when is Ca2+ saturated, whether CaM
dissociation takes place in two distinct phases: as reported by A. Persechini et al., when
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Figure 3.20: Ca2+ distribution in CaM N-lobe, C-lobe and other Ca2+ buffers on µs timescale.
(Reproduced from [31]).
.
Figure 3.21: General network of CaM reactions with target enzymes. (Reproduced from[92]).
.
CaM is bound to eNOS, Ca2+ dissociation takes place more rapidly at the N-terminal
resulting in enzyme inactivation. At a later stage release of Ca2+ from C-terminal take
place and the NOSCaM complex dissociates[79].
Recently Salerno at al. has reported the first detailed measurements of eNOS and
nNOS dissociation rates from CaM. Consistently with the presented reaction scheme
they have found two distinct dissociation rates in condition of high or zero Ca2+
concentration and a transition point between different rates at [Ca2+] ≃ 300 nM[68].
We have interpreted these data in the context of the model 3.21, simplifying it as much
as possible in order to achieve the minimal model that can account for exclusively
activation by saturated CaM and reported double phases dissociation mechanism. We
have considered two distinct enzyme states, labelled NOSCaM and NOSCaM∗. The
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first one corresponds to the active form of the complex where CaM is Ca2+ saturated
whether NOSCaM∗ corresponds to inactive state in which Ca2+ release from N-lobe
has taken place and enzyme activity is blocked. Dissociation of the complex could take
place both by the active and inactive form. The resulting model is shown in figure 3.22
where kNOS1 and kNOS2 are NOSCaM formation and dissociation rates for the active
form of the complex, kNOSeq is the equilibrium constant between active and inactive
states and kNOSd is the dissociation rate of the inactive state.
Figure 3.22: NOS activation model
NOSCaM∗ NOSCaM
2Ca2+
2Ca2+
2Ca2+
NOS+CaM NOS+CaM2N,2C
kNOSeq
kNOS2kNOS1kNOSd
In absence of more detailed information we considered the transition between active
and inactive state at instantaneous equilibrium. Hence fraction of the complex in the
inactive state results Ca2+ dependent as follow:
[NOSCaM∗]
[NOSCaM∗] + [NOSCaM]
=
1
1 + [Ca2+] ∗ kNOSeq
(3.19)
Kinetic parameters of our model were extrapolated from experimental data re-
ported in [68]. At high Ca2+ concentration the complex accumulates in the active
state therefore we have set dissociation rate from active state kNOS1 to that reported
to be 0.02 s−1 at high Ca2+ levels. When Ca2+ concentration approaches zero the
equilibrium is heavily shifted to the inactivated form so we have considered dissocia-
tion rate kNOSd equal to that reported in presence of the Ca
2+ chelator EDTA equal
to 0.22s−1[68] The dissociation rate results slow at high Ca2+ level but between 300
nM to 30 nM increase rapidly reaching value found in EDTA. Thus, to determine equi-
librium rate keq, we have considered that at 300 nM [Ca
2+] only 10% of the complex
is present in the inactive state whether at lower concentration the equilibrium is fast
shifted to inactive form. The resulting keq was found to be 100 µM
−2.
Finally, we need to extrapolate from experimental data the NOSCaM complex
formation rate. In order to estimate this parameter we considered reported measure-
ments of eNOS binding to CaM at saturating Ca2+ concentrations ([Ca2+] = 10 µM)
and constant eNOS concentration of 10 nM that results in a pseudo first order rate of
NOSCaM formation of 0.05s−1[31]. In such conditions NOSCaM concentration follows:
[NOSCaM](t) = [CaM]0
[NOS](1− e−([NOS]kNOS2+kNOS1)t)kNOS2
[NOS]kNOS2 + kNOS1
(3.20)
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where ([NOS]kNOS2 +kNOS1) corresponds to the pseudo first order rate of the process.
The resulting NOSCaM formation rate is kNOS2 =4.8 µM
−1 s−1.
The developed eNOS activation network was then coupled with previously de-
scribed NO production model. To couple those models we have assumed that every
state during NO synthesis could be put in a inactivated state when Ca2+ unbinds from
CaM N-lobe. Moreover we have considered that inactivated enzyme units could be
restored in their original state if Ca2+ binding takes place. The resulting model is
shown in figure 3.23.
Figure 3.23: Coupling of eNOS activation model to NO biosynthesis model. Every state of
the enzyme, labelled with the oxidative state of corresponding heme group, was doubled with
the addition of the corresponding inactive state.
Fe3Argi Fe
3Arga
2Ca2+
2Ca2+
......
NOS+CaM
2Ca2+
kNOSd
Fe3a
L-Arg
k1k′1
Fe3i
2Ca2+
2Ca2+
NOS+CaM
2Ca2+
kNOSd
NOS+CaMN2,C2
kNOS1
kNOS2
From Calcium to Nitric Oxide: first results
Equations resulting from our activation-reaction eNOS model were solved using the
Matlab ODE suite(MATLAB 8.1, The MathWorks Inc., Natick, MA, 2013) with ap-
propriate initial conditions. Concentration of eNOS, L-Arg, O2 and CaM were set at
physiological values reported in table 3.1. The system was balanced by slowly increas-
ing Ca2+ concentration to reach a basal intracellular Ca2+ concentration of 50 nM.
The system was considered at equilibrium when concentrations of every species in the
model changes less than 1% on a timescale of 103 s.
Starting from this condition we have studied the reaction of the system to intra-
cellular Ca2+ concentration changes both in case of rapid Ca2+ spikes or sustained
Ca2+ increases. Ca2+ spikes was found to take place in a large variety of cells with a
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duration of Ca2+ transient that can range from a few ms in excitable cells to around
1 s [12]. System reaction after a 1s Ca2+ spike is shown in figure 3.24.
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Figure 3.24: eNOS activation after a 1s full width at half amplitude (FWHA) Ca2+ spike.
Total [eNOS] = 0.045 nM, [CaM] = 8.8 µM.
When intracellular Ca2+ increases, rapid enzyme activation takes place. Then Ca2+
rapidly comes back to basal value and activated enzyme is converted into the inactive
form that dissociates from CaM in a few seconds. This mechanism provides a pool of
inactive enzyme that lasts for a few seconds after Ca2+ decreases but can be rapidly
restored to the active state whether if Ca2+ spike takes place.
eNOS activation in response to a sustained Ca2+ increase was also investigated.
As we have just shown when saturated CaM become available, a burst in active en-
zyme concentration immediately starts. When Ca2+ concentration remains high the
fraction of active enzyme continues to increase, reaching equilibrium after a few tens
of seconds. Therefore we have considered active enzyme fraction at equilibrium and
obtained its dependence on Ca2+ and CaM concentration. Simulations were carried
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Figure 3.25: eNOS activation after sustained Ca2+ increase. Total[eNOS] = 0.045nM,
[CaM] = 8.8µM.
out after equilibrating the system with different CaM concentration from 0 to 100
µM, then sustained Ca2+ signals with amplitude ranging between 0.1 to 3 µM were
considered as model input. Resulting values for active and inactive enzyme fraction
are reported in figures 3.26 and 3.27. Activation of the enzyme at different CaM con-
centration occurs when intracellular Ca2+ exceeds a threshold value of approximately
500 nM, such a prediction is not far from experimental values first reported by Cheung
et al. who measured an activation value from 200 nM to 400 nM[25]. Moreover when
CaM concentration falls under 2 µM this threshold rapidly increases. Recently Chen
et al. performed measurements of eNOS activation under the condition of saturating
Ca2+ level of 100 µM at different levels of CaM concentration. Their measurements
shows that in such conditions eNOS EC50 for CaM is approximately of 60 nM[108].
Running our model in the same condition yielded a predicted EC50 of 24 nM that is
a fairly good result considering measurement uncertainty and that our model is based
on rate constant measured in rather different conditions.
We have observed that the dependence of the active enzyme fraction at equilibrium
on CaM concentration shown a simple Michaeils Menten kinetics. A more complex be-
haviour was observed for the dependence on intracellular [Ca2+]c due to its cooperative
binding with CaM lobes. Thus we have developed a simple effective description of en-
zyme activation at steady state. We described eNOS binding to saturated CaM by
means of simple Michaelis Menten kinetics:
[NOSCaM]
[NOS]0
=
1
1 + α[CaM(Ca)2N,2C]
(3.21)
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We modelled Ca2+ binding reaction with CaM considering independent cooperative
binding at the two lobe, each one described by means of a Hills function.
[CaM(Ca)2N,2C]
[CaM]0
=
(
[Ca2+]n
β + [Ca2+]n
)2
(3.22)
On the whole eNOS active fraction versus Ca2+ and CaM concentration was interpo-
lated by the relation:
[NOSCaM]
[NOS]0
=
1
1 + α
[CaM]0
(
[Ca2+]n
β+[Ca2+]n
)2 (3.23)
Such relation described quite well the simulated data, coefficients value obtained from
Least-Square fit are α = 0.14µM and β = 2.49µM2. The Hill coefficient n must
be integer[40] and is interpreted as the number of ligand molecules that are required
to bind to a receptor to produce a functional effect. For this reason we have set
n = 2 according also with Hill coefficient for Ca2+ binding to CaM lobes reported in
literature[71].
Ca2+ and CaM concentration do not affect only enzyme fraction that can reach
the active state but also the speed of such process. We have investigated such effect
introducing the activation time of the enzyme, defined at a fixed Ca2+ and CaM con-
centration as the time needed to reach half maximum of the active fraction achievable
in such conditions. Results are shown in figure 3.28
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Figure 3.26: Contour plot of eNOS active fraction at equilibrium as a function of CaM
concentration and sustained Ca2+ signals amplitude. eNOS activation starts at Ca2+ level
above 0.5 µM. Simulations carried on at CaM concentration also higer than 10 µM did not
show significative changes in activation pattern.
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Figure 3.27: eNOS inactive fraction at equilibrium as a function of CaM and Ca2+ concen-
tration.
.
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Figure 3.28: eNOS activation time as a function of Ca2+ and CaM concentration.
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Figure 3.29: eNOS active fraction interpolated with equation 3.23.
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3.2.3 NO production in focal PDT
The goal of this study was to use our model of eNOS activation to predict NO pro-
duction rate in response to Ca2+ signals recorded in PDT experiments. Based on our
studies, estimated [Ca2+]c values of ∼ 400 nM in PDT experiments seems insufficient
to justify eNOS activation. Nevertheless, is well known that [Ca2+]c represents only
the mean Ca2+ concentration inside the cell and that specific cellular processes in
different regions of the cell are regulated by localized regions of high Ca2+, called mi-
crodomains[11]. Such domains are formed at sites where Ca2+ enters the cytoplasm ei-
ther at the cell surface or at the internal stores and are a key element of Ca2+ signalling
in which Ca2+ concentration can reach values up to 200-300 µM [63]. Moreover,it was
also reported that eNOS co-localize with caveolin-1[2], a protein involved in formation
and maintenance of small invaginations of plasma membranes called caveolae, that was
demonstrated to be a site of Ca2+ microdomains[76], suggesting a fundamental role of
microdomains also in eNOS activation.
Considering that fPDT triggers apoptosis in target and bystander cells, we could
reasonably expect that local Ca2+ concentration is high enough to induce a maximum
activation of eNOS. Thus, we have rescaled recorded Ca2+ signals by a factor of 10, in
order to obtain an approximated estimate of Ca2+ concentration at the microdomain
level, capable of inducing maximum eNOS activation.
Rescaled Ca2+ concentration values for every cell of a fPDT experiment, were used
as input for eNOS activation model described in previous sections, whose equations
were solved using the Matlab ODE suite (MATLAB 8.1, The MathWorks Inc., Natick,
MA, 2013) in order to obtained NO production rate. Results are shown in figure
3.30. Since enzyme concentration inside the cell is unknown, NO production rate was
normalized to enzyme concentration. Production rates for every cell obtained by this
model were then inserted in the diffusion model defined by equations 3.13 and 3.14.
NO concentration in bystander cells, selected at increasing distance from the target
cell, was then compared to the enzymatic NO component of NO signal, extrapolated in
section 3.2.1. Results shown in figure 3.31 suggest that this model of eNOS activation
and NO production accounts for the rapid NO production evoked by PDT, under
the hypotheses of Ca2+ microdomains involvement in enzyme activation, but fails
to predict subsequent enzyme inactivation. These results also suggest that local Ca2+
dynamics is crucial to modulate NO production. Effectively, Ca2+ microdomains levels
could be significantly higher than intracellular average concentration only during Ca2+
release from intracellular stores whereas, at a later stage, Ca2+ distribution inside the
cytoplasm is homogenized by diffusion, providing one possible scheme to understand
observed enzyme inactivation.
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Figure 3.30: NO production rate expressed as a fraction of enzyme concentration (b), in
response to recorded Ca2+ increase (a). Simulation parameters were set to [CaM] = 10 µM,
[Arg] = 10 µM, [O2] = 200 µM,T = 37°C, Ca
2+ transient amplitude was scaled by a factor 10
in order to obtain an approximated estimate of Ca2+ concentration at the microdomain level.
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Figure 3.31: NO concentration within bystander cells selected at increasing distance from
the photoactivation spot(b), NO concentration in the same cells due to NO production evoked
by fPDT, extrapolated as described in section 3.2.1 (a).
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Conclusions and Future
Perspectives
This study describes, for the first time, a new modality of NO production during
fPDT. Similarly to radiotherapy, PDT is capable of triggering bystander responses in
non-irradiated cells, acting as an inducer of immunogenic cell death, thus efficiently
promoting antitumor immune response[100]. Prior work suggested the involvement
of NO and RNS in bystander effects. However, the methods applied for NO track-
ing, such as chemiluminescence and spectroscopy, suffered from low spatial resolution
and also required complicated instrumentation. The widely used fluorescent probes
for NO, including o-diaminonaphthalene (DAN), o-diaminofluoresceins (DAFs) and o-
diaminocyanines (DACs), react with oxidized NO products rather than NO itself, thus
their fluorescence-response does not necessarily reflect real-time NO production[58].
The present work is based on the novel fluorescent probe CuFl, which reacts rapidly
and specifically with NO over other potentially interfering molecules[59]. The method
developed here for accurately analysing CuFl signals allowed us to dynamically monitor
NO in real-time. Our data provide the first direct evidence of NO involvement in
bystander response during PDT.
A newly developed method for voltage imaging of gap junction network showed that
our cultured cells form a vast syncytium. Consistent with this result, pharmacological
interference experiments with connexin inhibitors unveiled a crucial role played by gap
junction channels in the bystander effect and cell-to-cell propagation of the apoptotic
signal. Simultaneous imaging of CuFl and Fura-2 showed the NO signals in bystander
cells spatially and temporally associated to an intercellular wave of Ca2+.
The shape of NO signals indicates a dual mechanism whereby NO is directly re-
leased from the target cell upon photoactivation of AlPc and rapidly diffuses to by-
stander cells. NO levels are further elevated through enzymatic production driven by
the Ca2+ wave which develops concurrently during PDT. By analyzing our data in
the light of simple NO diffusion model, we were able to estimate the contribution of
the diffusive component relative to enzymatic production, which amounts to at least
50% of the total NO signals evoked during PDT in bystander cells. Altogether, our
data supported the notion that constitutive NOS activity is critical for the spreading
of bystander responses and death signals following fPDT.
53
CHAPTER 4. Conclusions and Future Perspectives
Therefore we developed a mathematical description of Ca2+-mediated eNOS ac-
tivation, based on experimental data reported in literature. The reliability of the
model was tested by comparing significant parameters predicted by simulations with
corresponding values found in literature. The model we propose is the first complete
mathematical description of Ca2+ to NO transduction mediated by eNOS.
The discrepancy we find between experimental and simulation-based predictions
of [NO] variation induced by [Ca2+]c signals is easily ascribed to the role of Ca
2+
microdomains in eNOS regulation. Reconstructing the dynamics of Ca2+ concentration
in microdomains from [Ca2+]c measurements is a complex task that can be achieved
by stochastic deconvolution[15]. This will be subject of a future endeavour.
In summary, our data provide important new insight in the molecular mecha-
nisms of PDT mediated bystander effect and support the notion that PDT represent
a promising option for cancer treatment which is certainly worth further development.
Understanding and quantitatively modelling the molecular basis of the effects evoked
by this therapy, could in principle guide the use of appropriate combinations of Ca2+
modulating agents, NO-donors and gap junction enhancers to promote tumor eradica-
tion by maximizing bystander effects[83].
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Appendix A
eNOS model equations
A.1 NO production
d[Fe3+]
dt
=− k1[Arg][Fe
3+] + k′1[Fe
3+Arg]− k2[Fe
3+] + k14[Fe
3+NO]+ (A.1)
k13[Fe
2+NO][O2] + k8[Fe
3+NOHA]− k′8[Fe
3+][NOHA]
d[Arg]
dt
=0 (A.2)
d[Fe3+Arg]
dt
=k1[Fe
3+][Arg]− (k3 + k
′
1)[Fe
3+Arg] (A.3)
d[Fe2+]
dt
=k2[Fe
3+]− k4[Fe
2+][Arg] + k′4[Fe
2+Arg] + k9[Fe
2+NOHA]− (A.4)
k′9[Fe
2+][NOHA]
d[Fe2+Arg]
dt
=k3[Fe
3+Arg] + k4[Fe
2+][Arg]− k′4[Fe
2+][Arg]− (A.5)
k5[Fe
2+Arg][O2] + k
′
5[Fe
3+O−2 Arg]
d[Fe3+O−2 Arg]
dt
=k5[Fe
2+Arg][O2]− k6[Fe
2+O−2 Arg]− k
′
5[Fe
3+O−2 Arg] (A.6)
d[Fe2+NOHA]
dt
=k7[Fe
3+NOHA]− k10[Fe
2+NOHA][O2] + k
′
10[Fe
3+O−2 NOHA] (A.7)
−k9[Fe2+NOHA] + k
′
9[Fe
2+][NOHA]
d[Fe3+O2NOHA]
dt
=k10[Fe
2+NOHA][O2]− k11[Fe
3+O2,−NOHA]− (A.8)
k′10[Fe
3+O−2 NOHA]
d[Fe3+NOHA]
dt
=k6[Fe
3+O−2 Arg]− k7[Fe
3+NOHA]− k8[Fe
3+NOHA]+ (A.9)
k′8[Fe
3+][NOHA]
d[Fe3+NO]
dt
=k11[Fe
3+O−2 NOHA]− k14[Fe
3+NO]− k12[Fe
3+NO] (A.10)
d[Fe2+NO]
dt
=k12[Fe
3+NO]− k13[Fe
2+NO][O2] (A.11)
d[NO]
dt
=k14[Fe
3+NO] (A.12)
d[NOHA]
dt
=k8[Fe
3+NOHA]− k′8[Fe
3+][NOHA] + k9[Fe
2+NOHA]− (A.13)
k′9[Fe
2+][NOHA]
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A.2 Enzyme activation
d[CaM]
dt
=− 2(kN1 + kC1)[CaM][Ca
2+] + k′N1[CaM1N]+
k′C1[CaM1C] + kNOSd[NOSCaM
∗] (A.14)
d[CaM1N]
dt
=+ 2kN1[CaM][Ca
2+] + k′C1[CaM1N,1C] + 2k
′
N2[CaM2N]
− (kN2 + 2kC1)[CaM1N][Ca
2+]− k′N1[CaM1N] (A.15)
d[CaM1C]
dt
=+ 2kC1CaM[Ca
2+] + k′N1[CaM1N,1C] + 2k
′
C2[CaM2C]−
(kC2 + 2kN1)[CaM1C][Ca
2+]− k′C1[CaM1C] (A.16)
d[CaM2N]
dt
=+ kN2[CaM1N][Ca
2+] + k′C1[CaM2N,1C]− 2k
′
N2[CaM2N]
− 2kC1[CaM2N][Ca
2+] (A.17)
d[CaM2C]
dt
=+ kC2[CaM1C][Ca
2+] + k′N1[CaM1N,2C]− 2kN1[CaM2C]
[Ca2+]− 2k′C2[CaM2C] (A.18)
d[CaM1N,1C]
dt
=+ 2kC1[CaM1N][Ca
2+] + 2kN1[CaM1C][Ca
2+] + 2k′N2[CaM2N,1C]
+ 2k′C2[CaM1N,2C]− (k
′
N1 + k
′
C1 − kN2[Ca
2+]− kC2[Ca
2+])[CaM1N,1C]
(A.19)
d[CaM1N,2C]
dt
=+ 2kN1[CaM2C][Ca
2+] + kC2[CaM1N,1C][Ca
2+] + 2k′N2[CaM2N,2C]
− k′N1[CaM1N,2C]− 2k
′
C2[CaM1N,2C]− kN2[CaM1N,2C][Ca
2+] (A.20)
d[CaM2N,1C]
dt
=+ 2kC1[CaM2N][Ca
2+] + kN2[CaM1N,1C][Ca
2+] + 2k′C2[CaM2N,2C]
− k′C1[CaM2N,1C]− 2k
′
N2[CaM2N,1C]− kC2[CaM2N,1C][Ca
2+] (A.21)
d[CaM2N,2C]
dt
=+ kC2[CaM2N,1C][Ca
2+] + kN2[CaM1N,2C][Ca
2+]− 2(k′C2
+ k′N2)[CaM2N,2C]− kNOS1[CaM2N,2C][NOS] + kNOS2[NOSCaM] (A.22)
d[NOS]
dt
=− kNOS1[CaM2N,2C][NOS] + kNOS2[NOSCaM] + kNOSd[NOSCaM
∗] (A.23)
d[NOSCaM]
dt
=− kNOSd[NOSCaM
∗]− kNOS2[NOSCaM] + kNOS1[CaM2N,2C][NOS] (A.24)
[NOSCaM∗] =
[NOSCaM]
[Ca2+] ∗ kNOSeq
(A.25)
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Appendix B
Fluorescence imaging with dual
wavelength indicators
Optical measurements of the intracellular concentration of selected ion species is a
well known technique to access ions concentration, such as Ca2+, with high spatial
and temporal resolutions. Such techniques rely on the ability of the fluorescent probe,
namely fluorescent dye, to provide useful information about its environment by suitable
changes in its fluorescent properties in response to changes in the parameter to be mea-
sured. For biological applications changes in fluorescent yield, shift in the excitation
or emission spectra or a combination of these effects are considered appropriate.
In dual wavelength indicators a shift in excitation (or emission) spectra takes place
when target ions bind to the fluorophore, therefore excitation spectra of free and
bound fluorophore cross in a point called isosbestic point. Such properties allow to
get ratio-metric measurements of target ions concentration by evaluating the ratio be-
tween fluorescence emission at two wavelengths located on opposite sides relative to the
isosbestic point. Considering ratio measurements rather than single wavelength fluo-
rescence increase leads to a great improvement in target ion concentration assessment
and neutralizes artefacts caused by photo-bleaching. Imaging with dual excitation flu-
orophores requires the sequential excitation at two wavelengths that can be achieved
by switching rapidly between two light sources.
In order to achieve quantitative imaging of Ca2+ ions concentration we need to
link it with the fluorescence ratio. Fluorescence emission by two wavelengths dyes is
characterized by four parameters Sf1 and Sf2 for Ca
2+-free dye at wavelength λ1 and
λ2 and Sb1 and Sb2 for Ca
2+-bound dye. Then fluorescence ratio results:
F1 = Sf1 [P] + Sb1 [CaP] (B.1)
F2 = Sf2 [P] + Sb2 [CaP] (B.2)
R =
F1
F2
=
Sf1 + Sb1
[Ca2+]
kd,p
Sf2 + Sb2
[Ca2+]
kd,p
(B.3)
where kd,p is the dissociation constant, [P] is the concentration of free fluorophore,
[CaP] the concentration of bound fluorophore and the equilibrium condition [CaP] =
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[P][Ca2+]/kd,p has been used. Rearranging such relation, introducing Rmin = Sf1/Sf2 ,
that means the ratio when Ca2+ concentration approaches zero, and Rmax = Sb1/Sb2 ,
the ratio at saturating Ca2+ concentration, we obtained the Grynkiewicz equation:
[Ca2+]c =
kd,p(R −Rmin)
Rmax −R
(
Ff
Fb
)
(B.4)
Notice that the applicability of the Grynkewicz equation depends on the assumption
of a 1:1 dye-Ca2+ complexation with a sufficiently diluted medium where fluorescence
is proportional to concentration. Moreover Rmin, Rmax and Ff/Fb must be measured
on the same instrumentations to calibrate the system.
Fura-2 (Invitrogen/Molecular Probes) is an extensively used ratiometric Ca2+ dye.
For imaging experiments, cells were loaded with Fura-2 acetoxymethyl (AM) esters,
an analogue of Fura-2 that can passively diffuse across cell membranes. Once inside
the cells, these esters are cleaved by intracellular esterases to yield cell-impermeant
fluorescent indicator[99].
Figure B.1: Fura-2 ratiometric dye for calcium imaging excitation spectra
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C.1 Fura-2 Calibration
As previously introduced in appendix B, measurements of intracellular Ca2+ concen-
tration were made from ratio values by application of the Grynkiewicz equation:
[Ca2+]c =
kd,p(R −Rmin)
Rmax −R
(
Ff
Fb
)
(C.1)
where R is the ratio between fluorescence emission intensity excited at 365 nm divided
by the intensity excited at 385 nm. Both fluorescence emissions are a sum of different
contribution that form the background of recorded signals and must be subtracted
in order to obtain a reliable estimate of intracellular Ca2+. Particularly, fluorescence
emission at 365nm and 385 nm excitation wavelength are an overlap of Fura-2 emis-
sion, cells autofluorescence, AlPc fluorescence emission and crossover emission of CuFl
(Bleed Through) due to its broad spectral profile. Cell autofluorescence and AlPc
fluorescence were measured from cells loaded with the PS only, subjected to the same
experimental protocol used in PDT experiments, comprehensive of single cell photo-
activation. CuFl bleed-through was measured from cell cultures loaded with the PS
and CuFl and was reported as the ratio between the emission at 365nm or 385nm and
that at 460nm excitation wavelengths. Rmin and Rmax refer to minimum and maxi-
mum ratio values recorded in situ with 10µM ionomycin in the presence of 2mM EGTA
solution and 20mM Ca2+ solution, respectively;
Ff
Fb
is the ratio of the fluorescence val-
ues of the Ca2+-free and Ca2+ bound forms at 380 nm; the kd of Fura2 at 22°C was
assumed to be 280nM[46]. Every calibration measurement was repeated with at least
three different samples, mean values of every parameter were reported in table C.1 on
the following page.
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Table C.1: Mean values for calibration parameters.
Camera offset 1488
FAlPc,365 + FAuto,365 37
FAlPc,385 + FAuto,385 48
FAlPc,460 + FAuto,460 75
FCuF l,365
FCuF l,460
1.64%
FCuF l,365
FCuF l,460
5.88%
s 11.06
Rmin 0.42
Rmax 13.04
C.2 AlPc effects on dyes fluorescent emission
In order to avoid possible direct effects of AlPc or its photo-activation by-products on
Fura-2 or CuFl fluorescence emissions experimental test were carried on.
CuFl test experiments were carried on in small (∼ 100µm diameter) aqueous vesi-
cles of the solution formed in Sylgard on a coverslip. The same aqueous solution used
for cell perfusion during imaging experiments, addicted with 20µM CuFl and 10µM
AlPc, was disperded as small vesicles by stirring 10µl into 100µl Sylgard, dropping on
a coverslip and allowing 30min for air bubble to come out[19]. Sample position was
adjusted in order to observe a single vesicle in the frame and its fluorescence emission
was monitored during 60s irradiation with 671nm solid state laser focused on the spec-
imen as previously described. Resulting fluoresce emission was not affected by AlPc
photo-activation and resulting singlet oxygen production.
Comparable experiments were carried for Fura-2 with similar solution addicted
with 10µM AlPc and Fura-2 15 µM. Due the opacity of Sylgard to UV radiation such
experiments were conducted on a drop of solution placed above a coverslip. Only a
small increase in Fura-2 emission both at 360nm and 380nm excitation wavelengths
were registered. Such increase also results in an enhancement of fluorescence ratio.
This result does not affect Ca2+ measurements carried on in PDT experiments because
indeed in that case activated AlPc is only present in target cell and not in nearby
bystander cells.
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Figure C.1: CuFl bleed through at 385nm excitation wavelength during AlPc photoactivation,
showed as raw fluorescence data and fraction of fluorescence at 460nm excitation.
Figure C.2: CuFl aqueous vesicle in Sylgard
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Figure C.3: Fura2 fluorescence emission and ratio in a drop of experimental solution during
AlPc photoactivation
Figure C.4: CuFl fluorescence emission into an aqueous vesicle in Sylgard during AlPc
photoactivation
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